Measurements Using the Alkaline Comet Assay Predict Bladder Cancer Cell Radiosensitivity

Overview

Journal Br J Cancer

Specialty Oncology

Date 2003 Dec 17

PMID 14676805

Citations 23

Authors

M A L Moneef

B T Sherwood

K J Bowman

R C Kockelbergh

R P Symonds

W P Steward

J K Mellon

G D D Jones

Affiliations

Soon will be listed here.

Abstract

In the UK, the two main treatments of invasive bladder cancer are radiotherapy or cystectomy. However, approximately 50% of patients undergoing radiotherapy fail to respond. If tumour radiosensitivity could be predicted in advance, it may be possible to improve control rates significantly by selecting for radiotherapy those patients whose tumours are radiosensitive. Additionally, patients who would benefit from surgery would be identified earlier. The alkaline comet assay (ACA) is a sensitive method for the detection of DNA strand break damage in cells. In the present study, using six bladder cancer cell lines of differing radiosensitivities, cell survival was compared to the manifestation of radiogenic DNA damage as assessed by ACA. For all the cell lines, the extent of comet formation strongly correlates with cell killing (R2>0.96), with a greater response being noted in radiosensitive cells. In repair studies, measures of residual damage correlate with survival fraction at 2 Gy (R2>0.96), but for only five of the cell lines. Finally, cells from human bladder tumour biopsies reveal a wide range of predicted radiosensitivies as determined by ACA. Overall, these studies demonstrate ACA to be a good predictive measure of bladder cancer cell radiosensitivity at low dose, with potential clinical application.

Citing Articles

Specific spectral sub-images for machine learning evaluation of optical differences between carbon ion and X ray radiation effects.

Negoita R, Ilisanu M, Irimescu I, Popescu R, Tudor M, Mihailescu M Heliyon. 2024; 10(15):e35249.

PMID: 39170121 PMC: 11336423. DOI: 10.1016/j.heliyon.2024.e35249.

A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage.

Ji Y, Karbaschi M, Abdulwahed A, Quinete N, Evans M, Cooke M J Vis Exp. 2022; (183).

PMID: 35635461 PMC: 9486971. DOI: 10.3791/63559.

assays for investigating the FLASH effect.

Adrian G, Ruan J, Paillas S, Cooper C, Petersson K Expert Rev Mol Med. 2022; 24:e10.

PMID: 35225211 PMC: 9884768. DOI: 10.1017/erm.2022.5.

Evaluation of the Major Steps in the Conventional Protocol for the Alkaline Comet Assay.

Karbaschi M, Ji Y, Abdulwahed A, Alohaly A, Bedoya J, Burke S Int J Mol Sci. 2019; 20(23).

PMID: 31810189 PMC: 6929057. DOI: 10.3390/ijms20236072.

Assessing Radiosensitivity of Bladder Cancer : A 2D vs. 3D Approach.

Bodgi L, Bahmad H, Araji T, Al Choboq J, Bou-Gharios J, Cheaito K Front Oncol. 2019; 9:153.

PMID: 30941305 PMC: 6433750. DOI: 10.3389/fonc.2019.00153.

References

Marples B, Longhurst D, EASTHAM A, West C . The ratio of initial/residual DNA damage predicts intrinsic radiosensitivity in seven cervix carcinoma cell lines. Br J Cancer. 1998; 77(7):1108-14. PMC: 2150146. DOI: 10.1038/bjc.1998.184. View

Ward J . The yield of DNA double-strand breaks produced intracellularly by ionizing radiation: a review. Int J Radiat Biol. 1990; 57(6):1141-50. DOI: 10.1080/09553009014551251. View

Price M, McKelvey-Martin V, Robson T, Hirst D, McKeown S . Induction and rejoining of DNA double-strand breaks in bladder tumor cells. Radiat Res. 2000; 153(6):788-94. DOI: 10.1667/0033-7587(2000)153[0788:iarodd]2.0.co;2. View

Woudstra E, Roesink J, Rosemann M, Brunsting J, Driessen C, Orta T . Chromatin structure and cellular radiosensitivity: a comparison of two human tumour cell lines. Int J Radiat Biol. 1996; 70(6):693-703. DOI: 10.1080/095530096144581. View

Olive P . DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int J Radiat Biol. 2001; 75(4):395-405. DOI: 10.1080/095530099140311. View

McKeown S, Robson T, Price M, Ho E, Hirst D, McKelvey-Martin V . Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation. Br J Cancer. 2003; 89(12):2264-70. PMC: 2395295. DOI: 10.1038/sj.bjc.6601426. View

Peters L, McKay M . Predictive assays: will they ever have a role in the clinic?. Int J Radiat Oncol Biol Phys. 2001; 49(2):501-4. DOI: 10.1016/s0360-3016(00)01469-3. View

Malyapa R, WRIGHT W, Roti J . Radiation sensitivity correlates with changes in DNA supercoiling and nucleoid protein content in cells of three Chinese hamster cell lines. Radiat Res. 1994; 140(3):312-20. View

Jenkins B, Martin J, Fowler C, HOPE-STONE H, Blandy J . The fate of G3pT1 bladder cancer. Br J Urol. 1989; 64(6):608-10. DOI: 10.1111/j.1464-410x.1989.tb05319.x. View

10.

Studer U, Danuser H, Merz V, Springer J, Zingg E . Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment. J Urol. 1995; 154(1):49-56. View

11.

Singh N, McCoy M, Tice R, Schneider E . A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 175(1):184-91. DOI: 10.1016/0014-4827(88)90265-0. View

12.

Shipley W, Rose M, Perrone T, Mannix C, Heney N, Prout Jr G . Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol. 1985; 134(4):679-83. DOI: 10.1016/s0022-5347(17)47381-2. View

13.

Moldenhauer G, Momburg F, Moller P, Schwartz R, Hammerling G . Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer. 1987; 56(6):714-21. PMC: 2002400. DOI: 10.1038/bjc.1987.276. View

14.

Quilty P, Duncan W, Chisholm G, Fowler J, Hargreave T, NEWSAM J . Results of surgery following radical radiotherapy for invasive bladder cancer. Br J Urol. 1986; 58(4):396-405. DOI: 10.1111/j.1464-410x.1986.tb09093.x. View

15.

Duncan W, Quilty P . The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol. 1986; 7(4):299-310. DOI: 10.1016/s0167-8140(86)80059-7. View

16.

Evans H, Ricanati M, Horng M, Jiang Q, MENCL J, Olive P . DNA double-strand break rejoining deficiency in TK6 and other human B-lymphoblast cell lines. Radiat Res. 1993; 134(3):307-15. View

17.

Dunne A, Price M, Mothersill C, McKeown S, Robson T, Hirst D . Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells. Br J Cancer. 2003; 89(12):2277-83. PMC: 2395286. DOI: 10.1038/sj.bjc.6601427. View

18.

West C, Davidson S, Roberts S, Hunter R . The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer. 1997; 76(9):1184-90. PMC: 2228123. DOI: 10.1038/bjc.1997.531. View

19.

Olive P, Wlodek D, Banath J . DNA double-strand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res. 1991; 51(17):4671-6. View

20.

Malyapa R, WRIGHT W, Roti J . DNA supercoiling changes and nucleoid protein composition in a group of L5178Y cells of varying radiosensitivity. Radiat Res. 1996; 145(2):239-42. View